Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

10.4%

14 terminated/withdrawn out of 134 trials

Success Rate

84.8%

-1.7% vs industry average

Late-Stage Pipeline

17%

23 trials in Phase 3/4

Results Transparency

13%

10 of 78 completed trials have results

Key Signals

18 recruiting10 with results10 terminated4 withdrawn

Enrollment Performance

Analytics

N/A

52(55.3%)

Phase 2

15(16.0%)

Phase 4

12(12.8%)

Phase 3

11(11.7%)

Phase 1

3(3.2%)

Early Phase 1

1(1.1%)

94Total

N/A(52)

Phase 2(15)

Phase 4(12)

Phase 3(11)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (134)

Showing 20 of 134 trials

NCT07524335Phase 3Not Yet Recruiting

Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial

Role: lead

NCT05269589Not ApplicableRecruiting

Home-based Heat Therapy for Type 2 Diabetes

Role: lead

NCT04428944Not ApplicableActive Not Recruiting

STrategies for Catheter Ablation of peRsistent Atrial Fibrlllation

Role: collaborator

NCT04688190Recruiting

CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry

Role: collaborator

NCT06101784Phase 1Completed

Single and Multiple Ascending Oral Doses of Avenanthramide

Role: lead

NCT04907253Phase 2Completed

Quercetin in Coronary Artery By-pass Surgery

Role: lead

NCT05633810Phase 3Recruiting

COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes

Role: lead

NCT07257198Phase 3Recruiting

Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone

Role: lead

NCT07389837Not ApplicableNot Yet Recruiting

Maple Syrup Carbohydrate Dose-Response on 20-km Cycling Time-Trial Performance

Role: collaborator

NCT07391358Not ApplicableNot Yet Recruiting

DAPT Strategy in HBR Patients Undergoing Complex PCI Following ACS: Second-Phase Beta Testing of a Patients Decision Aid

Role: lead

NCT05105919Early Phase 1Active Not Recruiting

Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes

Role: lead

NCT04936607Not ApplicableRecruiting

ImproviNg rEnal Outcomes Following Coronary angiograPhy and/or percuTaneoUs coroNary intErventions

Role: lead

NCT05702463Phase 1Recruiting

Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II

Role: lead

NCT06388668Recruiting

Lipid Testing After Myocardial Infarction at the Montreal Heart Institute

Role: lead

NCT04970888Not ApplicableRecruiting

Comparing the Effects of Combining Cognitive and Physical Exercise Training on Cognition, and Cerebral Blood Flow Regulation in Men and Women With Chronic Heart Failure

Role: lead

NCT07230886Not ApplicableNot Yet Recruiting

Prospective Reduction Of Transplant Complications Through Enhanced Preservation Therapy to Prevent Primary Graft Dysfunction

Role: collaborator

NCT07213531Recruiting

Enhanced Valves Interventions and Safe AI Generated End Results

Role: lead

NCT05450328Phase 2Not Yet Recruiting

Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation

Role: lead

NCT03536312Not ApplicableRecruiting

Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance

Role: collaborator

NCT06637293Not ApplicableNot Yet Recruiting

Deployment and Evaluation of Artificial Intelligence Software for Electrocardiogram Analysis and Management in Primary Care

Role: lead